Free tool
FAERS Monitor: Tetracaine Hydrochloride
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 210821 or its brand name (Tetracaine Hydrochloride, Tetracaine Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
133
Serious
118
89% of reports
Hospitalization
29
Death reported
17
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- toxic anterior segment syndrome31
- nausea15
- syncope15
- aqueous fibrin14
- inflammation14
- abdominal discomfort12
- pain12
- sudden death12
- muscle spasms11
- oropharyngeal pain11
- hypersensitivity9
- hypotension9
- bradycardia8
- cardio-respiratory arrest8
- circulatory collapse8
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 11 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 15 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 8 |
| 2022 | 27 |
| 2023 | 6 |
| 2024 | 7 |
| 2025 | 12 |
| 2026 | 17 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,026 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| aqueous fibrinSignal | 14 | 59897.7 | 33168.0 | 565,675 |
| toxic anterior segment syndromeSignal | 31 | 4629.6 | 3381.6 | 134,924 |
| sudden deathSignal | 12 | 179.5 | 104.6 | 1,955 |
| circulatory collapseSignal | 8 | 74.3 | 37.9 | 508 |
| inflammationSignal | 14 | 42.9 | 26.1 | 533 |
| cardio-respiratory arrestSignal | 8 | 30.3 | 15.5 | 198 |
| bradycardiaSignal | 8 | 23.9 | 12.2 | 153 |
| syncopeSignal | 15 | 23.7 | 14.7 | 305 |
| oropharyngeal painSignal | 11 | 18.8 | 10.7 | 169 |
| abdominal discomfortSignal | 12 | 11.3 | 6.6 | 104 |
| muscle spasmsSignal | 11 | 9.5 | 5.4 | 76 |
| hypersensitivitySignal | 9 | 7.7 | 4.1 | 46 |
| hypotensionSignal | 9 | 7.1 | 3.8 | 42 |
| painSignal | 12 | 3.1 | 1.8 | 15 |
| nauseaSignal | 15 | 3.0 | 1.9 | 19 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.